| 2026 | | Clinical, immunologic, and treatment burden of nonsteroidal anti-inflammatory drug–exacerbated cutaneous disease
Annals of allergy, asthma & immunology, 136(3). : 295-300, 2026 | 박해심, 신유섭, 예영민 |
| 2026 | | The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D Study
Allergy, 81(2). : 468-479, 2026 | 예영민 |
| 2026 | | Distinct Serum MicroRNA Signatures and mRNA Decay Pathway Dysregulation in NSAID-Exacerbated Chronic Urticaria
International journal of molecular sciences, 27(2). : 904-904, 2026 | 예영민, 우현구 |
| 2026 | | Lifetime Atopic Dermatitis is Associated With Risk of Autoimmune Thyroid Disease: Evidence From a Nationwide Study
Allergy, asthma & immunology research, 18(1). : 145-154, 2026 | 김진희, 예영민, 임형렬, 홍세리 |
| 2026 | | Serum Haptoglobin as a Predictor of Treatment Response in Patients With Chronic Spontaneous Urticaria
Clinical and translational allergy, 16(1). : e70148-e70148, 2026 | 예영민, 최보윤 |
| 2025 | | Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
Clinical and translational allergy, 15(11). : e70110-e70110, 2025 | 예영민 |
| 2025 | | Distinct Cytokine Profiles in Chronic Spontaneous Urticaria Refractory to H1-Antihistamines Compared to Healthy Controls
Clinical and experimental allergy, 55(11). : 1147-1149, 2025 | 예영민 |
| 2025 | | Clinical Relevance of Immunologic Diagnosis of Shrimp Allergy in Adults
Allergy, asthma & immunology research, 17(3). : 359-370, 2025 | 예영민, 최보윤 |
| 2025 | | Large-Scale Analysis of Age and Sex Effects on Corrected QT and JT Intervals: Insights From Hospital-Based Controls and Moxifloxacin-Treated Cases
Clinical and translational science, 18(6). : e70263-e70263, 2025 | 예영민 |
| 2025 | | Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study
Allergy, 80(3). : 750-761, 2025 | 예영민 |
| 2025 | | Therapeutic Efficacy of YH35324 on FcεRIα-Mediated Mast Cell/Basophil Activation
Allergy, asthma & immunology research, 17(2). : 181-195, 2025 | 박해심, 예영민, 장재혁 |
| 2024 | | Distinct Clinical Profiles of IgE and IgG Autoantibodies to Thyroid Peroxidase in Chronic Spontaneous Urticaria
Allergy, asthma & immunology research, 16(6). : 626-639, 2024 | 박해심, 예영민, 장재혁, 최보윤 |
| 2024 | | Can Vaccinations Trigger or Exacerbate Chronic Urticaria?
Allergy, asthma & immunology research, 16(6). : 567-570, 2024 | 예영민 |
| 2024 | | Role of Platelet-Activating Factor in the Pathogenesis of Chronic Spontaneous Urticaria
International journal of molecular sciences, 25(22). : 12143-12143, 2024 | 예영민 |
| 2024 | | Association of HLA-B∗13:01 with DRESS and HLA-A∗31:01 with eosinophilia in SJS/TEN induced by carbamazepine
The journal of allergy and clinical immunology. In practice, 12(12). : 3436-3438.e1-e3, 2024 | 예영민 |
| 2024 | | Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis
Allergy, asthma & immunology research, 16(3). : 308-316, 2024 | 예영민 |
| 2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study
The journal of allergy and clinical immunology. Global, 3(2). : 100245-100245, 2024 | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma
The Journal of allergy and clinical immunology, 153(4). : 998-1009.e1-e9, 2024 | 박해심, 신유섭, 예영민 |
| 2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study
International immunopharmacology, 130. : 111706-111706, 2024 | 박해심, 예영민 |
| 2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice
The World Allergy Organization journal, 17(3). : 100879-100879, 2024 | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies
Yonsei medical journal, 65(2). : 120-128, 2024 | 예영민 |
| 2024 | | CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
Clinical and translational allergy, 14(1). : e12328-e12328, 2024 | 예영민 |
| 2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
Lancet (London, England), 403(10422). : 147-159, 2024 | 예영민 |
| 2023 | | Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor
Allergy, 78(12). : 3166-3177, 2023 | 강호철, 박해심, 신민경, 예영민, 조중현, 최보윤 |
| 2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease
Allergy, asthma & immunology research, 15(5). : 682-694, 2023 | 박해심, 예영민 |
| 2023 | | Skin Test–Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study
The journal of allergy and clinical immunology. In practice, 11(11). : 3454-3462.e1, 2023 | 예영민 |
| 2023 | | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
The Journal of allergy and clinical immunology, 152(5). : 1095-1106, 2023 | 예영민, 이영수 |
| 2023 | | Treatment with biological products for chronic urticaria
Journal of the Korean Medical Association, 66(9). : 537-544, 2023 | 예영민 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
Journal of Korean medical science, 38(32). : e247-e247, 2023 | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2023 | | Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
Allergy, asthma & immunology research, 15(4). : 496-511, 2023 | 박해심, 신유섭, 예영민 |
| 2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice
Annals of allergy, asthma & immunology, 131(2). : 209-216.e1-e2, 2023 | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2023 | | Real-World Disease Burden of Chronic Urticaria and Vaccine Hesitancy
Allergy, asthma & immunology research, 15(1). : 1-3, 2023 | 예영민 |
| 2023 | | Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease
Clinical and translational allergy, 13(3). : e12229-e12229, 2023 | 박해심, 예영민 |
| 2023 | | Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry
The World Allergy Organization journal, 16(1). : 100738-100738, 2023 | 예영민 |
| 2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea
The Korean journal of internal medicine, 37(5). : 1050-1060, 2022 | 박해심, 예영민 |
| 2022 | | A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization
Scientific reports, 12(1). : 21568-21568, 2022 | 예영민 |
| 2022 | | Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria
PloS one, 17(8). : e0273415-e0273415, 2022 | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
| 2022 | | Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)
The World Allergy Organization journal, 15(2). : 100629-100629, 2022 | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
| 2021 | | Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins
PloS one, 16(7). : e0254898-e0254898, 2021 | 예영민, 이영수, 장재혁 |
| 2021 | | Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria
International archives of allergy and immunology, 182(11). : 1066-1071, 2021 | 박해심, 예영민 |
| 2021 | | Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
Experimental & molecular medicine, 53(6). : 1036-1045, 2021 | 박해심, 신유섭, 예영민, 최영우 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma
Annals of allergy, asthma & immunology, 127(1). : 109-115.e1, 2021 | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea
The journal of allergy and clinical immunology. In practice, 9(2). : 929-936.e1-e7, 2021 | 예영민 |
| 2021 | | Erratum: Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission
Allergy, asthma & immunology research, 13(4). : 675-675, 2021 | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Establishment of reference intervals of serum immunoglobulins in healthy korean adults
Allergy, asthma & immunology research, 13(4). : 671-674, 2021 | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | COVID-19 vaccine-associated anaphylaxis and allergic reactions: Consensus statements of the KAAACI urticaria/angioedema/anaphylaxis working group
Allergy, asthma & immunology research, 13(4). : 526-544, 2021 | 박해심, 예영민, 이수영 |
| 2021 | | Screening for autoimmune comorbidities in patients with chronic spontaneous urticaria: Which tests to whom
Allergy, asthma & immunology research, 13(4). : 521-523, 2021 | 예영민 |
| 2021 | | Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria
Allergy, asthma & immunology research, 13(3). : 498-506, 2021 | 예영민 |
| 2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence
Allergy, asthma & immunology research, 13(3). : 420-434, 2021 | 박해심, 신유섭, 예영민 |
| 2021 | | Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission
Allergy, asthma & immunology research, 13(3). : 390-403, 2021 | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
